Merck Hit with Class Action Over Alleged Scheme to Maintain Pediatric Rotavirus Vaccine Monopoly
March 10, 2023 A class action alleges an “anticompetitive scheme” on the part of Merck has caused customers to pay artificially inflated prices for its pediatric rotavirus vaccine, RotaTeq.